west virginia tirzepatide lawsuit Eli Lilly sues Mochi Health and others for 'deceptive' marketing Lilly releases Zepbound® (tirzepatide) single-dose

Rawshani A, Rawshani A, Gudbjrnsdottir S (2017) Mortality and cardiovascular disease in type 1 and type 2 diabetes

Exploring the Nephroprotective Potential of Tirzepatide: Insights From GIP and GLP-1 Agonism in Diabetic Nephropathy 5.2.1

However, you must consider the shelf life of reconstituted peptides

Currently, yes semaglutide has proven cardiovascular benefit from the SELECT trial (2023), which demonstrated significant reduction in major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in patients with obesity and established heart disease

This translates to approximately 4560 minutes of activity most days of the week